Reticulate scleroderma after isolated limb perfusion with melphalan.
Landau
M
M
Department of Dermatology, Tel Aviv--Elias Sourasky Medical Center, and Sackler School of Medicine, Tel Aviv University, Israel.
Brenner
S
S
Gat
A
A
Klausner
J M
JM
Gutman
M
M
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D006801:Humans; D007871:Leg Ulcer / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000009:adverse effects*; D008875:Middle Aged; D010477:Perfusion; D012509:Sarcoma / Q000188:drug therapy; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000473:pathology
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan